pharmaphorum’s digital magazine Deep Dive is published online six times a year and reaches a global audience of highly engaged pharmaceutical and biotechnology decision-makers.

Each Deep Dive issue combines a focus topic – either sales and marketing, digital, market access, oncology, patients or R&D – with an additional mixture of thought-provoking content and commercial opportunities include:

• Features (interview style article, up to 2,000 words)
• Features (client-written article, up to 2,000 words)
• 12 questions with...
• Case studies
• Company profiles
• Digital advertising
• Edition sponsorship

The Deep Dive team can offer full editorial support in planning and writing articles, including the inclusion of appropriate graphics and links. Articles receive a one-month cycle of promotion and a digital and print PDF versions of articles are provided after the issue is published.

Previous companies that have benefitted from this included: Alexion, AstraZeneca, Beigene, Daiichi Sankyo, EVERSANA, Frontiers Health, Healthware, Lumanity, M3, NIHR, Phesi, PurpleLeaf Strategy, Real Chemistry, Research Partnership, Syneos Health, and Viseven.

Upcoming Deep Dive issues for 2026 will include:

October 2026: Rare disease

Rare disease is an increasingly important focus for pharma, as advances in science, regulatory incentives and new approaches to diagnosis reshape how companies develop and bring treatments to patients, including:

  • Sustainable financing for one-and-done gene therapies
  • What big pharma is buying in rare disease – and why
  • Innovation in neuro and metabolic rare diseases
  • The FDA’s Rare Disease Evidence Principles in practice
December 2026: Impact

Our impact issue aims to look beyond the headline-making scientific and technological innovations to focus on how these developments affect patients and the world around us. This includes:

  • Sustainability efforts
  • Health equity 
  • Patient engagement
  • Storage and transportation
     
Upcoming themes for 2027
  • GLP-1s
  • Access
  • Oncology
  • AI
  • Rare disease
  • Impact

     

Let us help you connect with your clients, email advertising@pharmaphorum.com or download our media pack for more information about Deep Dive and our other offerings.